Remember the old days when we were pleased that Generex had a two-fold pipeline? Things have changed so fast, that I can't even cite the various aspects of this company.

We still have AE37 and a partnership with Merck and Keytruda, a treatment I see advertised on TV every day. We also have a buccal delivery system, except I'm not sure what it's supposed to deliver. My preference is some form of pain management.

Then we have pharmacies and wound care and intestinal drugs. I'm sure I've missed other initiatives. However, by next week we should see some evidence of a revenue stream(s). That may be exciting.

There's no doubt who is responsible for the success or failure of the company. Joe is at the helm, and we're along for the ride.